Recent tests already show hope that aged garlic extract can prevent damage to eyes, kidneys, blood vessels and skin
Can aged garlic extract really help diabetics preserve their vision? People who have diabetes often suffer from damage to their eyes, kidneys, blood vessels and skin. This is caused by high sugar levels in a process called glycation. Researchers at Manchester University in England have already shown that garlic, in liquid form, may be a potent block on glycation in the lab. Now the same researchers will study the effect of liquid Kyolic® Aged Garlic Extract in a clinical trial involving 70 patients with Type 2 diabetes, the most common form of diabetes.
The researchers are looking at whether a natural product can help prevent diabetes or play a role in the treatment of the disease. “One of the other things that people with diabetes have is increased free radical activity which could have a role in these complications,” said Dr. Nessar Ahmed, molecular biologist at the university’s department of biological sciences. Aged garlic extract’s antioxidant compounds fight free radicals which damage healthy cells, and have been widely studied.
Aged garlic extract is produced by a long extraction process, up to two years, creating an odorless product rich in active, bioavailable compounds. This extract is standardized to ensure consistent levels and ratios of these unique compounds. In fact, some of these beneficial compounds are not found in regular raw garlic or other garlic supplements.
More than 375 scientific studies have been completed on aged garlic extract, done in major universities and research centers. These studies have focused on various aspects of garlic’s health benefits including the reduction of multiple risk factors such as cholesterol and high blood pressure lowering effects; homocysteine control; inhibition of LDL oxidation (reducing sticky cholesterol); blood-thinning effect; and stimulating blood circulation by widening blood vessels. In addition, other aged garlic extract research has concentrated on immune enhancement, improving memory (prevention of Alzheimer’s), protecting liver function and anti-cancer effects.
Kyolic® is a trademark and a product of Wakunaga of America Company, a subsidiary of Wakunaga Pharmaceutical Company.
Biography – Nassar Ahmed, Ph.D.
Nassar Ahmed received his Ph.D. in Medical Biochemistry from Oxford University, England. Dr. Ahmed is currently a Senior Lecturer in Medical Biochemistry, Dept of Biological Sciences, Manchester Metropolitan University. In addition, he has published extensive research studies on glycation; the role of growth factors (FGF-2, PDGF) in diabetic wound healing; the role of free radicals and antioxidants in disease; and lead and manganese poisoning in childhood iron deficiency.
Dr. Ahmed also is currently co-ordinating the Joint Supervision Programme with the King Abdul Aziz University in Jeddah, Saudi Arabia. His research group, based at the King Fahad Medical Research Centre, is investigating the effect of high monounsaturated fat diet supplemented with various antioxidants on the oxidative status, lipid profile and glycaemic control in Type II Saudi diabetic patients; and glycation and oxidative stress in type II diabetes mellitus in Saudi Arabia.
In July 2003, Dr. Ahmed was awarded the Young Investigators Award by the World Association for Societies in Pathology and Laboratory Medicine (WASPaLM). He also is
Honorary Associate Professor, Department of Biochemistry, Ziauddin Medical University, Karachi, Pakistan; and adjunct Professor, HEJ Research Institute of Chemistry, University of Karachi, Karachi, Pakistan.
Dr. Ahmed holds membership or fellowship of a number of UK professional bodies including The Biochemical Society, the Association of Clinical Biochemists, the Institute of Biology (Biomed Sci Div), the British Diabetic Association, Royal College of Pathologists (trainee), Institute of Biomedical Science, and Registration Council of Scientists in Health Care.